Adelene Q. Perkins

2011

In 2011, Adelene Q. Perkins earned a total compensation of $1.4M as President and Chief Executive Officer at Infinity Pharmaceuticals, a 33% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$301,000
Option Awards$526,604
Salary$519,000
Other$7,830
Total$1,354,434

Perkins received $526.6K in option awards, accounting for 39% of the total pay in 2011.

Perkins also received $301K in non-equity incentive plan, $519K in salary and $7.8K in other compensation.

Rankings

In 2011, Adelene Q. Perkins' compensation ranked 4,572nd out of 10,747 executives tracked by ExecPay. In other words, Perkins earned more than 57.5% of executives.

ClassificationRankingPercentile
All
4,572
out of 10,747
58th
Division
Manufacturing
1,635
out of 3,960
59th
Major group
Chemicals And Allied Products
340
out of 1,033
67th
Industry group
Drugs
205
out of 781
74th
Industry
Pharmaceutical Preparations
160
out of 571
72nd
Source: SEC filing on April 4, 2012.

Perkins' colleagues

We found three more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2011.

2011

Julian Adams

Infinity Pharmaceuticals

President of R&D

2011

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

2011

Pedro Santabarbara

Infinity Pharmaceuticals

Chief Medical Officer

News

You may also like